Transforming the way diseases are detected, tracked, treated, and understood.
No new events at this time.
#ICYMI – CEO Dr. Caroline Loew shares career advice for moving from pharma to #biotech, discusses our response to the pandemic, and outlines our clinical programs with @BioPharmaMike on @DRGInsights’ “Conversations in Healthcare.”
#GlympseBio CEO @CarolineLoew and co-founder @SNBhatia recently spoke with @MIT News about the discovery that led to our platform of synthetic #biosensors and their journey from concept to company.
Today we announced that Jessica Atkinson has joined the #GlympseBio team as SVP of #businessdevelopment. Her deep industry experience will support our mission to transform disease detection and monitoring. Welcome to the team, Jessica!
#GlympseBio is seeking experienced #Scientists focused on #PeptideSynthesis or High Throughput Screening.
We are continuing to build a strong, values-driven organization focused on our people and rigorously pushing the boundaries. Learn more at http://www.glympsebio.com/careers